Elevation Oncology, Inc.

Historical 13F Holders

Symbol
ELEV
CUSIP
28623U101
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 28623U101 since 12/18/2024, largest first.

Filer % of Class Filed
Biotechnology Value Fund L P 13G/A
7.0% 5/15/2025
Event 3/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (8)
Tang Capital Management LLC 13G/A
4.99% 8/14/2025
Event 6/30/2025
Vanguard Group Inc 13G/A 4.4% 1/30/2025
Event 12/31/2024
Goldman Sachs Group Inc 13G/A
2.8% 2/6/2025
Event 12/31/2024
BlackRock, Inc. 13G/A 0.6% 7/17/2025
Event 6/30/2025
BML Investment Partners, L.P. 13D/A 0% 7/28/2025
Event 7/23/2025
Farallon Capital Partners, L.P. 13G/A
0% 5/7/2025
Event 3/31/2025
Frazier Life Sciences Public Fund, L.P. 13G/A
0% 8/14/2025
Event 7/23/2025
Logos Global Management LP 13G/A
0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q3 1 2.00 k $720
2025 Q2 66 29.5 M $10.8M
2025 Q1 74 33.8 M $8.76M
2024 Q4 72 40.0 M $22.5M
2024 Q3 70 45.9 M $27.5M
2024 Q2 82 52.1 M $140M
2024 Q1 64 44.0 M $226M
2023 Q4 33 25.8 M $13.9M
2023 Q3 42 28.0 M $18.6M
2023 Q2 41 31.5 M $48.8M
2023 Q1 28 16.2 M $30.9M
2022 Q4 28 14.4 M $13.7M
2022 Q3 26 14.3 M $16.1M
2022 Q2 28 15.4 M $21.5M
2022 Q1 32 18.7 M $47.2M
2021 Q4 36 18.3 M $110M
2021 Q3 23 15.9 M $123M
2021 Q2 37 16.2 M $217M